Cargando…

Secondary mitral regurgitation—Insights from microRNA assessment

BACKGROUND: While secondary mitral regurgitation (sMR) is associated with adverse outcome in heart failure with reduced ejection fraction (HFrEF), key pathophysiologic mechanisms remain poorly understood and might be elucidated by microRNAs (miRNA/miR), that were recently related to cardiac remodell...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spinka, Georg, Bartko, Philipp E., Pavo, Noemi, Freitag, Claudia, Zlabinger, Katrin, Prausmüller, Suriya, Arfsten, Henrike, Heitzinger, Gregor, Mascherbauer, Julia, Hengstenberg, Christian, Gyöngyösi, Mariann, Hülsmann, Martin, Goliasch, Georg
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900984/ https://www.ncbi.nlm.nih.gov/pubmed/32780418 http://dx.doi.org/10.1111/eci.13381

Ejemplares similares

Burden, treatment use, and outcome of secondary mitral regurgitation across the spectrum of heart failure: observational cohort study
por: Bartko, Philipp E, et al.
Publicado: (2021)

Phenotyping progression of secondary mitral regurgitation in chronic systolic heart failure
por: Arfsten, Henrike, et al.
Publicado: (2019)

An Integrated Imaging and Circulating Biomarker Approach for Secondary Tricuspid Regurgitation
por: Spinka, Georg, et al.
Publicado: (2020)

Malnutrition outweighs the effect of the obesity paradox
por: Prausmüller, Suriya, et al.
Publicado: (2022)

Plasma Neprilysin Displays No Relevant Association With Neurohumoral Activation in Chronic HFrEF
por: Prausmüller, Suriya, et al.
Publicado: (2020)

Neutrophil Activation/Maturation Markers in Chronic Heart Failure with Reduced Ejection Fraction
por: Prausmüller, Suriya, et al.
Publicado: (2022)

Metabolomics implicate eicosanoids in severe functional mitral regurgitation
por: Hofbauer, Thomas M., et al.
Publicado: (2022)

Circulating dipeptidyl peptidase (cDPP3)—A marker for end‐stage heart failure?
por: Pavo, Noemi, et al.
Publicado: (2022)

Renin Trajectories and Outcome in Stable Heart Failure with Reduced Ejection Fraction (HFrEF) on Contemporary Therapy: A Monocentric Study from an Austrian Tertiary Hospital Outpatient Clinic
por: Han, Emilie, et al.
Publicado: (2023)

Neprilysin inhibition does not alter dynamic of proenkephalin‐A 119‐159 and pro‐substance P in heart failure
por: Arfsten, Henrike, et al.
Publicado: (2021)

Relevance of Neutrophil Neprilysin in Heart Failure
por: Prausmüller, Suriya, et al.
Publicado: (2021)

Performance of the recommended ESC/EASD cardiovascular risk stratification model in comparison to SCORE and NT-proBNP as a single biomarker for risk prediction in type 2 diabetes mellitus
por: Prausmüller, Suriya, et al.
Publicado: (2021)

Increased concentrations of bioactive adrenomedullin subsequently to angiotensin‐receptor/neprilysin‐inhibitor treatment in chronic systolic heart failure
por: Arfsten, Henrike, et al.
Publicado: (2020)

Neprilysin as a Biomarker: Challenges and Opportunities
por: Pavo, Noemi, et al.
Publicado: (2020)

Increased granulocyte membrane neprilysin (CD10) expression is associated with better prognosis in heart failure
por: Pavo, Noemi, et al.
Publicado: (2019)

Inflammation-Based Scores as a Common Tool for Prognostic Assessment in Heart Failure or Cancer
por: Arfsten, Henrike, et al.
Publicado: (2021)

A streamlined, machine learning-derived approach to risk-stratification in heart failure patients with secondary tricuspid regurgitation
por: Heitzinger, Gregor, et al.
Publicado: (2023)

The inflammation‐based modified Glasgow prognostic score is associated with survival in stable heart failure patients
por: Cho, Anna, et al.
Publicado: (2020)

Transcatheter Versus Surgical Valve Repair in Patients with Severe Mitral Regurgitation
por: Koschutnik, Matthias, et al.
Publicado: (2022)

Heart Failure With Reduced Ejection Fraction Is Characterized by Systemic NEP Downregulation
por: Pavo, Imre J., et al.
Publicado: (2020)

The circulating form of neprilysin is not a general biomarker for overall survival in treatment-naïve cancer patients
por: Pavo, Noemi, et al.
Publicado: (2019)

Increased resting heart rate and prognosis in treatment‐naïve unselected cancer patients: results from a prospective observational study
por: Anker, Markus S., et al.
Publicado: (2020)

GDF‐15 in solid vs non‐solid treatment‐naïve malignancies
por: Arfsten, Henrike, et al.
Publicado: (2019)

Sacubitril/valsartan is well tolerated in patients with longstanding heart failure and history of cancer and improves ventricular function: real-world data
por: Frey, Maria Klara, et al.
Publicado: (2021)

Molecular Imaging of Angiogenesis in Cardiac Regeneration
por: Mandic, Ljubica, et al.
Publicado: (2016)

Circular RNAs in Cardiac Regeneration: Cardiac Cell Proliferation, Differentiation, Survival, and Reprogramming
por: Mester-Tonczar, Julia, et al.
Publicado: (2020)

Large Animal Models of Cell-Free Cardiac Regeneration
por: Spannbauer, Andreas, et al.
Publicado: (2020)

Invasive Hemodynamic Assessment and Procedural Success of Transcatheter Tricuspid Valve Repair—Important Factors for Right Ventricular Remodeling and Outcome
por: Dannenberg, Varius, et al.
Publicado: (2022)

Comparative Effect of MSC Secretome to MSC Co-culture on Cardiomyocyte Gene Expression Under Hypoxic Conditions in vitro
por: Kastner, Nina, et al.
Publicado: (2020)

Novel Identified Circular Transcript of RCAN2, circ-RCAN2, Shows Deviated Expression Pattern in Pig Reperfused Infarcted Myocardium and Hypoxic Porcine Cardiac Progenitor Cells In Vitro
por: Mester-Tonczar, Julia, et al.
Publicado: (2021)

Percutaneous bail-out in severe acute mitral regurgitation: when surgery is not an option
por: Nitsche, Christian, et al.
Publicado: (2021)

Clinical Impact of Pre-Procedural Percutaneous Coronary Intervention in Low- and Intermediate-Risk Transcatheter Aortic Valve Replacement Recipients
por: Winter, Max-Paul, et al.
Publicado: (2021)

A Real World 10-Year Experience With Vascular Closure Devices and Large-Bore Access in Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation
por: Heitzinger, Gregor, et al.
Publicado: (2022)

Pacemaker lead-associated tricuspid regurgitation in patients with or without pre-existing right ventricular dilatation
por: Riesenhuber, Martin, et al.
Publicado: (2021)

Parameters associated with therapeutic response using peritoneal dialysis for therapy refractory heart failure and congestive right ventricular dysfunction
por: Pavo, Noemi, et al.
Publicado: (2018)

Identification of Gene Expression Signatures for Phenotype-Specific Drug Targeting of Cardiac Fibrosis
por: Lukovic, Dominika, et al.
Publicado: (2023)

Transcatheter treatment by valve-in-valve and valve-in-ring implantation for prosthetic tricuspid valve dysfunction
por: Dannenberg, Varius, et al.
Publicado: (2021)

Human recombinant activated protein C-coated stent for the prevention of restenosis in porcine coronary arteries
por: Lukovic, Dominika, et al.
Publicado: (2015)

Evolution of outcome and complications in TAVR: a meta-analysis of observational and randomized studies
por: Winter, Max-Paul, et al.
Publicado: (2020)

Transcatheter aortic valve replacement (TAVR) leads to an increase in the subendocardial viability ratio assessed by pulse wave analysis
por: Müller, Claudia, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_m2ev64u881bd674btkt9kcvlfr